Researchers now know that MS starts way earlier than the clinical onset, creating the real possibility that MS could one day be controlled.

At ASHG in Boston, Eric Green received the society's Leadership Award and delivered an acceptance speech that moved the entire room.

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

BioAgilytix now operates 355,000-square-feet of laboratory facilities, including 24,000-square-feet dedicated to LC/MS.

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

The peptide lab is designed to produce a range of molecules, including linear peptides, cyclic peptides, and peptide-drug conjugates.

Researchers say findings help to bridge the structure of the genome to its function in managing how genes are turned on and off.

A new mechanism explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer.

Torino is a computational workflow that uses biobank-scale RNA-seq data to decode transcript structures and expression levels from read coverage alone.

In this GEN webinar, a distinguished panel of experts discuss next-generation expression systems, optimized screening methods, and integrated development strategies that are enabling higher-performing ...

Scientists suggest approach could be leveraged for a wide range of chemical applications, with complex, workflows streamlined into a rapid, single-step reaction.

Gut fungus reduces the brain’s preference for alcohol consumption, potentially leading to alternative treatment pathways for AUD.